Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.20    
    

BEYOND GENOMICS, INC.

40 Bear Hill Road

Waltham, MA 02451

March 2,
2003 

Dr. Robert
McBurney

20 Leslie Road

Newton, MA 02466 

Dear
Robert: 

        On
behalf of Beyond Genomics, I am delighted to offer you the position of Senior Vice President Research and Development and Chief Scientific
Officer reporting to me. In consideration for all your services to be rendered to the Company, you will be paid at a semi monthly rate of $9,166.67 (which is equivalent to an
annual rate of $220,000). You will also be eligible to receive an annual bonus opportunity of 30% of your base salary payable upon the achievement of company (50% of the bonus) milestones and
individual (50% of the bonus) milestones. 

        Should
you be terminated without cause during the first twelve months of your employment you will be entitled to continue your base salary for an additional six month from your
termination date. In addition, if terminated without cause during the first twelve months of your employment you will be entitled to have 25% of any stock options granted upon employment vest
immediately. 

        Upon
hire you will also be granted an option to purchase 400,000 shares of common stock of Beyond Genomics at an exercise price to be determined by the Board of Directors. This option
will vest 25% on the first anniversary of your start date and the remaining 75% quarterly over three years thereafter. 

        This
offer is valid through March 15, 2003 and we would like you to start work as soon as possible. 

        You
will be eligible to participate in the Company's benefit plans to the same extent as, and subject to the same terms, conditions and limitations applicable to, other Company employees
of similar rank and tenure. Summaries of each of the Company's benefit plans are available to you. In addition, you will be reimbursed for all reasonable out-of-pocket expenses
incurred during the performance of your duties. in accordance with the Company's reimbursement policies as established or modified from time to time by the Company. You will 

Dr.
Robert McBurney

February 14, 2003

Page #2 

also
be eligible for three (3) weeks vacation and twelve (12) holidays (9 scheduled and 3 floating) as set forth by the Company. 

        Nothing
herein shall create any obligation on the part of the Company. or any other person, to continue your employment. Your employment with the Company is at will which means either
the Company or you may terminate your employment relationship with the Company at any time and for any or no reason. with or without cause. and with or without notice. Beyond Genomics reserves the
right to alter. supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any time in its sole and absolute discretion and without
notice. 

        As
part of your employment with the company, you have and will be exposed to, and provided with, valuable confidential and/or trade secret information concerning the Company and its
present and prospective clients. As a result, in order to protect the Company's legitimate business interests, you agree, as a condition of your employment. to enter into an Employee
Non-Disclosure Agreement and a Non-Competition and Non-Solicitation Agreement. These documents are enclosed for your review and execution by the first day of your
employment. 

        Please
acknowledge acceptance of this employment offer by signing, dating, and indicating your start date below. Keep one copy for your files and return one executed copy to Nicole
Schaeffer, Director, Human Resources, prior to the expiration date of this offer. 

        Robert,
we look forward to having you on the Beyond Genomics team and creating significant value with you. 

	 	 	Very truly yours,
	 	 	 	 
	 	 	Beyond Genomics, Inc.
	 	 	 	 
	 	 	By:	/s/  N. STEPHEN OBER      
 N. Stephen Ober, MD, MBA
 President

	Accepted and Agreed to:	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	/s/  R. N. MCBURNEY      
Dr. Robert McBurney	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	3/10/03
 Start Date	 	 	 	 

QuickLinks

Exhibit 10.20QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.21    
    

April 9,
2004 

Mr. Steve
Martin

61 Carleton Road

Belmont, MA 02478 

Dear
Steve: 

        On
behalf of Beyond Genomics, Inc. ("Beyond Genomics" or the "Company), I am delighted to offer you the full-time position of Senior Vice President and  Chief Technology Officer commencing on
May 17, 2004. In this position you will report to the Chief Executive Officer. This is a key Executive
Management position within the company and will leverage your steep domain expertise, organizational and managerial skills. This position will allow you to design and implement strategic programs in
the life sciences leveraging our systems biology approach. In consideration for all your services to be rendered to the Company, you will be paid at a semi-monthly rate of $7,708.34 (which
is equivalent to an annual rate of $185,000). You will also be eligible to receive a bonus opportunity of $50,000, payable upon the achievement of company and individual milestones. 

        Additionally,
in order to help with your transition to Beyond Genomics, a $15,000 sign-on bonus will be paid to you on May 31, 2004. Should you terminate your
employment prior to your first anniversary, an appropriate prorated portion (i.e., monthly basis) of this sign-on bonus must be repaid to the Company prior to your departure. 

        Subject
to Board of Director approval, you will be granted an option to purchase 400,000 shares of common stock of Beyond Genomics at an exercise price to be as determined by the Board
of Directors. This option will vest 25% on the first anniversary of your start date and the remaining 75% quarterly over three years thereafter. 

        You
will be eligible to participate in the Company's benefit plans as of May 17, 2004 to the same extent as, and subject to the same terms, conditions and limitations applicable
to, other Company employees of similar rank and tenure. Summaries of each of the Company's benefit plans are available to you. In addition, you will be reimbursed for all reasonable
out-of-pocket expenses incurred during the performance of your duties, in accordance with the Company's reimbursement policies as established or modified from time to time by
the Company. Each calendar year you will be eligible for three (3) weeks vacation and twelve (12) holidays (initial employment year will be pro-rated), as set forth by the
Company. 

        Nothing
herein shall create any obligation on the part of the Company, or any other person, to continue your employment. Your employment with the Company is at will which means either
the Company or you may terminate your employment relationship with the Company at any time and for any or no reason, with or without cause, and with or without notice. Beyond Genomics reserves the
right to alter, supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any time in its sole and absolute discretion and without
notice. 

        As
part of your employment with the company, you have and will be exposed to, and provided with, valuable confidential and/or trade secret information concerning the Company and its
present and prospective clients. As a result, in order to protect the Company's legitimate business interests, you agree, as a condition of your employment, to enter into an Employee
Non-Disclosure Agreement and a Non-Competition and Non-Solicitation Agreement. These documents are enclosed for your review and should be completed prior to the
first day of your employment. 

        The
Company requires you to verify that the performance of your position at Beyond Genomics does not and will not breach any agreement entered into by you prior to employment with the
Company (i.e., you have not entered into any agreements with previous employers that are in conflict with your obligations to Beyond Genomics). To the extent any such agreements exist, please provide
us with appropriate copies for our review. You will also be required to provide us, for purposes of completing the INS 1-9 form, sufficient documentation to demonstrate your
eligibility to work in the United States. 

        Please
acknowledge acceptance of this employment offer by signing, dating, and indicating your start date below prior to April 16, 2004. Keep one copy for your files and return
one executed copy to Kimberly Borgen, Human Resources Manager and Controller, prior to the expiration date of this offer. 

        Steve,
we are excited at the prospect of you joining the Beyond Genomics team and believe you will be a pivotal player in revolutionizing the field of systems biology. 

	 	 	Very truly yours,

Beyond Genomics, Inc.
	 	 	 	 
	 	 	 	 
	 	 	By:	/s/  MUZAMMIL MANSURI      
 Muzammil Mansuri
 Chairman

	Accepted and Agreed to:	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	/s/  STEVE MARTIN          5-01-04
Steve Martin	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	May 24, 2004
 Start Date	 	 	 	 

QuickLinks

Exhibit 10.21QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.22    
    

April 5,
2007 

Mark
Shooman

1470 Beacon Street

Waban, MA 02468-1613 

Dear
Mark: 

        On
behalf of BG Medicine, Inc. (the "Company"), and the entire Board of Directors of the Company, I am delighted to offer you the position of Chief
Financial Officer reporting to me. We anticipate that your employment will start effective April 16, 2007 (the "Start Date"). In this key position you will have
responsibility for guiding the Company's financial goals and objectives, directing budgets and record-keeping, overseeing investment of the Company's funds and managing financial risks, supervising
cash management activities, executing capital-raising strategies to support the Company's expansion and strategic initiatives, as well as financial reporting to the Board of Directors and the Chief
Executive Officer. You will also be expected to perform such other and/or different services for the Company as may be assigned to you from time to time by the Board of Directors and the Chief
Executive Officer. 

        While
your employment with the Company will be full time, during your first month of such employment (unless extended by the Company), you will be permitted to offer consultation to your
now current employer, ONI Systems, Inc. so long as such consultation does not interfere with your duties to the Company, does not create any conflict of interest with the Company, is with the
consent of ONI Systems, Inc. and does not occupy a material part of your business time. 

        This
offer letter and the accompanying documents and agreements summarize and set forth important terms about your employment with the Company. As is generally true for Company
employees, you will be employed on an at-will basis, which means that neither you nor the Company are guaranteeing this employment relationship for any specific period of time. Either of
us may choose to end the employment relationship at any time, for any reason. In addition, you should understand that
the descriptions of benefits and other compensation arrangements set forth herein are meant to be summary in form and may be subject to change. If any benefit is subject to a benefit plan, the terms
of that plan will control. The Company reserves the right to alter, supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any
time in its sole and absolute discretion and without notice. 

        1.    Compensation.    

        a.    Salary.    Initially, your salary will be in the gross
semi-monthly amount of $9,375.00 (which is equivalent to an annual rate of $225,000). 

        b.    Annual Performance Bonus.    You will also be eligible to
receive an annual bonus of up to forty percent (40%) of your base salary, payable upon the achievement, as determined by the CEO and Board of Directors, of specific milestones to be mutually agreed
upon. 

        c.    Stock Options.    Subject to the terms of and contingent upon
your execution of a stock option agreement (the "Option Agreement") issued pursuant to the Company's 2001 Stock Option and Incentive Plan, as amended, and subject to Board approval, you will be
granted an option to purchase 400,000 shares of common stock of the Company at an exercise price equal to the fair market value of the stock at the time of the grant as determined by the Board of
Directors. This option will vest 25% on the first anniversary of your first day of employment and thereafter the remaining 75% shall vest on a quarterly basis on the last day of each quarter over a
period of three years, provided that you remain employed on the vesting day. Additionally, upon a "change of control" (as defined in the Option Agreement) of the Company during your employment by the
Company, 100% of your unvested options, at the time of such change of control, will immediately vest. 

        d.    Benefits.    You will be eligible to participate in the
Company's benefit plans to the same extent as, and subject to the same terms, conditions and limitations applicable to, other Company employees of similar rank and tenure. Summaries of each of the
Company's benefit plans are available to you. In addition, you will be reimbursed for all reasonable out-of-pocket expenses incurred during the performance of your duties, in
accordance with the Company's reimbursement policies as established or modified from time to time by the Company. Each calendar year you will be eligible to accrue up to four (4) weeks vacation
and up to twelve (12) holidays (initial employment year will be pro-rated), as set forth by the Company. 

        e.    Signing Bonus.    After your first thirty (30) days of
employment, you will be paid a signing bonus of $10,000, provided, however, that such amount shall not be paid if as of such date you have been given
notice of termination for Cause (as defined in the Option Agreement). This signing bonus is repayable by you to the Company if you voluntarily terminate your employment with the Company or you are
terminated by Cause (as defined in the Option Agreement) within twelve months following your first day of employment. The amount repayable by you shall decrease proportionately for each month you
remain employed following your first day of employment. 

        2.    Severance Pay and Benefits upon Termination of Employment.    As
explained, you will be employed as an at-will employee. Should the Company terminate your employment without Cause (as defined in the Option Agreement), and conditioned upon your execution
of a separation agreement which contains, among other things, a general release of claims, you will receive severance pay equivalent to six (6) months of your annual base salary and six
(6) months of health benefit continuation at the time of such termination. 

        3.    Certifications by You.    By signing this offer letter, you are
certifying to the Company that (i) your employment with the Company does not, and will not, require you to breach any agreement entered into by you prior to employment with the Company (i.e.,
you have not entered into any agreements with previous employers that are in conflict with your obligations to the Company); and (ii) to the extent you are subject to restrictive agreements
with any prior employer that may affect your employment with the Company, you have provided us with a copy of that agreement. Please understand that the Company does not want you to disclose any
confidential information belonging to a previous employer or to incorporate the proprietary information of any previous employer into the Company's proprietary information and expects that you will
abide by restrictive covenants to prior employers. 

        4.    Required I-9 Documentation.    For purposes of
completing the INS I-9 form, you must provide us sufficient documentation to demonstrate your eligibility to work in the United States on or before your first day of employment. If you
have any questions about what documentation you must provide, please contact Stacie Rader, our Vice President, Human Resources. 

        5.    Confidentiality and Other Obligations by You.    As part of your
employment with the Company, you have been, and will be, exposed to, and provided with, valuable confidential and/or trade secret information concerning the Company and its present and prospective
clients. As a result, in order to protect the Company's legitimate business interests, you agree, as a condition of your employment, to enter into the enclosed Employee Non-Competition,
Non-Solicitation, Confidentiality and Assignment of Inventions Agreement (the "Confidentiality Agreement"). You must sign and return the Confidentiality Agreement before beginning your
employment with the Company. 

        This
offer letter, together with the Confidentiality Agreement, the Option Agreement, the Change of Control Cash Severance Agreement and the other agreements specifically referred to
herein, embodies the entire agreement and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings
relating to the subject matter hereof. The Company may assign its rights and obligations hereunder to any person or entity that succeeds to all or substantially all of the Company's business. You may
not assign your rights and obligations hereunder without the prior written consent of the Company and any such attempted assignment by you without the prior written consent of the Company will be
void. This offer letter and the rights and obligations of the parties hereunder will be construed in accordance with and 

governed
by the law of the Commonwealth of Massachusetts, without giving effect to the conflict of law principles thereof. 

        Please
acknowledge acceptance of this employment offer by signing, dating, and indicating your start date below. Keep one copy for your files and return one executed copy to Stacie
Rader, Vice President, Human Resources. 

        Mark,
we look forward to having you on the team. 

	 	 	Very truly yours,
	 	 	 	 
	 	 	BG Medicine, Inc.
	 	 	 	 
	 	 	By:	/s/  PIETER MUNTENDAM      
 Pieter Muntendam, MD
 President and CEO

	Accepted and Agreed to:	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	/s/  MARK SHOOMAN      
Mark Shooman	 	 	 	 
	 	 	 	 	 
	May 7, 2007
 Start Date	 	 	 	 

QuickLinks

Exhibit 10.22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]